EP
TWST icon

Edgestream Partners’s Twist Bioscience TWST Stock Holding History

Edgestream Partners’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$616K Buy
+5,992
New +$390K 0.02% 753
2024
Q2 		– Sell
-7,061
Closed -$242K – 1041
2024
Q1 		$242K Buy
+7,061
New +$255K 0.01% 757

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Edgestream Partners's TWST Position: Q2 2026 in Review

Edgestream Partners opened a new position in Twist Bioscience (TWST) in Q2 2026: 5,992 shares worth $616K. The stake represents 0.02% of the portfolio and ranks #753 among its holdings. This is a return to the name: Edgestream Partners previously reported a position in TWST as recently as Q1 2024.

Edgestream Partners first reported a position in TWST in Q1 2024 and has held it in 2 quarters since. 338 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Edgestream Partners held 5,992 shares of Twist Bioscience worth $616K as of Q2 2026.
  • Twist Bioscience was a new Edgestream Partners position in Q2 2026.
  • Twist Bioscience made up 0.02% of Edgestream Partners's portfolio in Q2 2026, its #753 holding.
  • Edgestream Partners first reported a position in Twist Bioscience in Q1 2024 and has held it in 2 quarters since.
  • 338 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Edgestream Partners's 13F filing for Q2 2026, filed 11 Aug 2026.